︎
Thank you for joining us at #CRSy22!  ︎  (Re)visit #CRSy22 talks on Champalimaud Research Youtube!  ︎  Stay tuned for #CRSy23 on Neuroscience  ︎  #CRSy22 Booklet already available for consultation  ︎





October 19-21, 2022
Lisbon, Portugal

Cancer initiation and progression are orchestrated through local and systemic interactions between tumour and tumour-associated cells. A more detailed characterisation of these interactions has so far contributed to a new generation of antitumour strategies and to improved cancer prognosis. However, although we have gained increasing knowledge about the cellular and molecular constituents of tumour-promoting and tumour-suppressing microenvironments, an accurate map delineating the role of each of these constituents remains unavailable.

By bringing together experts who have greatly contributed to our understanding of the tumour microenvironment, the Champalimaud Research Symposium 2022 (#CRSy22) will provide access to the most recent developments in basic and clinical research in this complex area.
CRSy22 will take the form of a single-track scientific meeting with 18 invited speakers, talks selected from abstracts and 2 poster sessions, among other networking and social activities. The hybrid format will give delegates the option to attend and present their work either in-person or online. 

The Champalimaud Centre for the Unknown (CCU) in Lisbon, Portugal, is expected to receive 300 participants over 3 days at a venue with unique and remarkable features that we are certain will foster a lively and stimulating scientific meeting.

The Symposium Chairs,

Adriana Sánchez-Danés
Bruno Costa-Silva
Henrique Veiga-Fernandes

Tumour Cells and their Microenvironment

Meet the speakers


Invited



● Shahin Rafii, WCMC, USA [Keynote] Gerard Evan, Cambridge Uni, UK [Keynote] Fatima Cardoso, ChampalimaudF, PT [Keynote] Joan Massagué, MSKCC, USA [Keynote] Vera Gorbunova, RoAR & Rochester Uni, USA Jacky G.Goetz, Inserm, FR Yasuyuki Fujita, Kyoto Uni, JP Bruno Silva-Santos, IMM & FMUL, PT Markus Maeurer, ChampalimaudF, PT ● Leila Akkari, NKI & Oncode Institute, NL ● Jeffrey W. Pollard, Edinburgh Uni, UK Ana Luísa Correia, ChampalimaudF, PT ● Michelle Monje-Deisseroth, Stanford Uni & HHMI, USA Neta Erez, Tel Aviv Uni, IL Héctor Peinado Selgas, CNIO, ES Salvador Aznar Benitah, IRB Barcelona, ES Sarah-Maria Fendt, VIB-KU, BE Cédric Blanpain, ULB, BE



Selected



Sara Canato, ChampalimaudF, PT Sahar Israeli Dangoor, Tel Aviv Uni, IL Celso A. Reis, i3s & Porto Uni, PT Maria Bettencourt, ChampalimaudF, PT Jose M. Adrover, CSHL, USA Alexander Schäffer, ITBET, GE

● online

Venue


Inaugurated on October 5th 2010, the Champalimaud Centre for the Unknown is now a part of the important riverside area of Belém, near the magnificent Tower of Belém. This area, where the river Tejo meets the Atlantic Ocean, is of great historical significance as the great Portuguese pioneers sailed from this location to discover the “unknown” in the XV and XVI centuries.

The presence of the Champalimaud Centre for the Unknown leverages this historical heritage by creating an inspirational link between the discoveries of yesteryear and the epic adventure of scientific research. Here, everything converges in the creation of a unique atmosphere for the development of the most advanced multidisciplinary and translational research in the field of biomedicine. The building’s contemporary architecture, along with its functionality, offers outstanding conditions to investigators, academics and health professionals, from Portugal and beyond, to carry out work oriented towards excellence and practical results.

The Champalimaud Centre for the Unknown covers an area of 60,000m2 facing the river Tejo and comprises three large areas. The main building houses the Champalimaud Clinical Centre’s diagnostic and treatment facilities, an indoor garden, research laboratories and administrative services, all interlinked to promote discussion and collaboration between scientists, clinicians and other professionals. A tropical pergola-covered garden is at the heart of this structure.

The Champalimaud Centre for the Unknown is a state-of-the-art facility for science, medicine, technology and public use.

Meet the partners





                       
This symposium is supported by QuantOCancer Project funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 810653.